Achilles Therapeutics (ACHL) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Achilles Therapeutics has announced changes in its leadership, with Karl Peggs stepping down as Chief Medical Officer to dedicate more time to his roles at UCLH and NIHR UCLH BRC, but he will continue to advise the company. Matilde Saggese, previously Vice President and Medical Director, has been appointed as the Interim CMO.
For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.